Search This Blog

Tuesday, 2 October 2012

Management of Symptomatic Sacral Perineural Cysts




Recent article from China June 2012

 Symptomatic Sacral Perineural Cysts.China. Pdf.pdf
 Symptomatic Sacral Perineural Cysts.China. Pdf.pdf

page1image12672
page1image12944
page1image13216
page1image13488
page1image13760
page1image14032
page1image14304
page1image14576
page1image14848Management of Symptomatic Sacral Perineural Cysts
Jianqiang Xu1, Yongdong Sun1, Xin Huang1, Wenzhong Luan2*
1 Department of Neurosurgery, General Hospital of Fengfeng Group, Handan, China, 2 Department of Neurosurgery, Peking University People’s Hospital, Beijing, China
Abstract
Background: There has been no consensus on the optimal treatment of symptomatic sacral perineural cysts. Most previous reports concerning the management methods were either sporadic case reports or a series of limited cases. This study is to further optimize the management for patients with symptomatic sacral perineural cysts by analyzing the outcomes of a cohort of patients who were treated with different strategies.
Methods and Findings: We reviewed the outcomes of 15 patients with symptomatic sacral perineural cysts who were managed by three different modalities from 1998 through 2010. Six patients underwent microsurgical cyst fenestration and cyst wall imbrication. Seven patients underwent a modified surgical procedure, during which the cerebrospinal fluid leak aperture was located and repaired. Two patients were treated with medication and physical therapy. Outcomes of the patients were assessed by following up (13 months to 10 years). All of the six patients treated with microsurgical cyst fenestration and cyst wall imbrication experienced complete or substantial relief of their preoperative symptoms. However, the symptoms of one patient reappeared eight months after the operation. Another patient experienced a postoperative cerebrospinal fluid leakage. Six of the seven patients treated with the modified surgical operation experienced complete or substantial resolution of their preoperative symptoms, with only one patient who experienced temporary worsening of his preoperative urine incontinence, which disappeared gradually one month later. No new postoperative neurological deficits, no cerebrospinal fluid leaks and no recurrence were observed in the seven patients. The symptoms of the two patients treated with conservative measures aggravated with time.
Conclusions: Microsurgical operation should be a treatment consideration in patients with symptomatic sacral perineural cysts. Furthermore, the surgical procedure with partial cyst removal and aperture repair for prevention of cerebrospinal fluid leakage seemed to be more simple and effective.
Citation: Xu J, Sun Y, Huang X, Luan W (2012) Management of Symptomatic Sacral Perineural Cysts. PLoS ONE 7(6): e39958. doi:10.1371/journal.pone.0039958
Editor: Isaac Yang, University of California Los Angeles, United States of America
Received January 9, 2012; Accepted May 29, 2012; Published June 29, 2012
Copyright: ß 2012 Xu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no support or funding to report.
Competing Interests: The authors have declared that no competing interests exist. * E-mail: wzh_luan@163.com
Introduction
Sacral perineural cysts, which were also termed Tarlov cysts, are collections of cerebrospinal fluid (CSF) between the endoneurium and perineurium of the nerve root sheath near the dorsal root ganglion [1]. These lesions are quite common as an incidental finding on magnetic resonance imaging (MRI), and most of them are asymptomatic [2]. In a series of 500 consecutive MRI scans of the lumbosacral spine, Paulsen et al [3] recorded an incidence of 4.6%, of which 20% were symptomatic. Approximately 1% of sacral perineural cysts become large and cause symptoms related to local compression [3], which should be treated.
There has been no consensus on the optimal treatment of symptomatic sacral perineural cysts since it was first described by Tarlov in 1938 [4]. Many methods have been applied to treat these symptomatic lesions, with variable results. Lumbar CSF drainage, lumboperitoneal shunt, and cyst subarachnoid shunt were not effective as a therapy for symptomatic Tarlov cysts [2], [5], [6]. CT-guided percutaneous aspiration of the cyst with infusion of fibrin glue yielded mixed results, and this method was associated with a high rate of aseptic meningitis [3], [7], [8]. Favorable results have been obtained with microsurgical cyst fenestration and imbrication in several reports [2], [4], [9],
[10].However, there remains some difficulties such as postoper- ative CSF leakage and the cyst recurrence [2–9].
Most previous reports concerning the management methods were either sporadic case reports or series of limited cases [2], [4], [5], [10–14]. We therefore retrospectively reviewed 15 cases of sacral perineural cysts treated with different methods.
Methods
Between 1998 and 2010, 15 patients (nine men, six women) ranging from 23 to 60 years of age (mean, 37.8 yr) with symptomatic sacral perineural cysts were treated at General Hospital of Fengfeng Group (Table 1),whose follow-up is more than one year. The main symptoms and neurological deficits included low back pain or sacrococcygodynia (n = 12), sacral radiculopathy (n = 7), numbness (n = 6), sensory disturbance of the sacral dermatome (n = 9), claudication (n = 4), and bowel and bladder dysfunction (n = 6). Written informed consent was obtained from each patient. The study was approved by the Medical Ethical Committee of Peking University.
The diagnoses of sacral perineural cysts were confirmed for all patients by magnetic resonance imaging (MRI) studies. Besides the cysts, MRI also demonstrated additional pathological features in
page1image73288
PLoS ONE | www.plosone.org 1
June 2012 | Volume 7 | Issue 6 | e39958
Management of Symptomatic Sacral Perineurial Cysts
page2image2456

38 Questions to Ask Your Surgeon Before Having Back Surgery

38 Questions to Ask Your Surgeon Before Having Back Surgery

Various Type of Spinal Cord Cysts (tarlov)



www.neurosurgery.tv


Cysts of several different types may develop within the spinal canal and may come to medical attention by causing myelopathy or radiculopathy or as incidental findings. Intraspinal ganglion cysts and synovial cysts, thought to be rare in 1985, are encountered not infrequently in current neurosurgical practice.
There is some element of confusion in the classification of spinal cysts, and several schemes have been used. Part of the confusion comes from the various terms that have been applied to the same entities by different authors, and part comes from the imprecise description of the cysts in some of the case reports.
Another source of confusion is our incomplete knowledge of the origins of some of these lesions. As an example, intraspinal epithelial cysts that are lined by a single layer of cuboidal epithelium could be of neurenteric or neuroepithelial origin. In some of the reported cases, standard light and electron microscopic techniques have not been sufficiently precise to make this differentiation. At present it is possible to supplement such assessments by immunohistochemical studies which have the potential of permitting more accurate classification.
A final source of confusion is the fact that there is some degree of overlap between the groups. For example, there is a continuum of cases from spinal epidermoid cysts at one end to spinal teratomatous cysts at the other, and a similar continuum from simple spinal neurenteric cysts at one end to spinal teratomatous cysts at the other. Another area of overlap is among spinal perineurial cysts, meningeal diverticula along spinal nerve roots, and lateral spinal meningoceles.
Discussion here does not consider syringomyelia or hydromyelia; cysts associated with astrocytomas, ependymomas, or hemangioblastomas of the spinal cord; or meningoceles and meningomyeloceles that extend out of the confines of the spinal canal.
Spinal Extradural Cysts
Spinal extradural diverticula and cysts are of various types, but those that develop spontaneously, have connective tissue walls, and contain cerebrospinal fluid are probably variations on a theme. They can be grouped as congenital extradural spinal cysts, spinal perineurial cysts (Tarlov cysts), spontaneous meningeal diverticula along spinal nerve roots, and occult intrasacral meningoceles. The congenital extradural spinal cysts (also called developmental extradural arachnoidal cysts or extradural arachnoid cysts) typically come to medical attention during the second decade of life, whereas the other three types are diagnosed most often during the middle of life.
Congenital Extradural Spinal Cysts
Between 1898 and 1970, at least 115 cases of congenital extradural spinal cyst were described in the medical literature, and since then many additional cases have been reported. These cysts are most often located in the thoracic area and are diagnosed most frequently in patients under 30 years of age. The male/female ratio of occurrence is about 4: 3. Scheuermann's kyphosis dorsalis or kyphosis without epiphysitis has coexisted in almost half the cases overall and in two-thirds of the patients between 11 and 20 years of age (all of whom had cysts in the thoracic region).
Cysts in the lumbar and cervical regions tend to occur in persons past the age of 20, suggesting that the cysts arising within the relatively small thoracic spinal canal become symptomatic earlier in life than those arising within the larger cervical or lumbosacral areas.
The congenital extradural spinal cyst, also referred to as an extradural arachnoid cyst, is attached by a narrow pedicle to the dura mater, usually either in the midline posteriorly or posterolaterally at the attachment of the dural sleeve covering a dorsal nerve root. The cyst may or may not communicate with the subarachnoid space. Several such cysts may be present in the same patient, though they usually are solitary. Microscopically, the cyst may be lined by a flattened layer of cells resembling arachnoidal cells, but the rest of its wall is composed of avascular collagenous connective tissue.
Most of the reported cases have been sporadic rather than familial. Several hypotheses have been advanced to explain their origin, all of which imply a congenital defect of some sort. No matter what their exact origin, such cysts appear to enlarge by hydrostatic pressure and CSF pulsations (perhaps with a ball-valve mechanism) until for some reason their communication with the spinal subarachnoid space becomes obliterated.
The clinical course of the patient with a congenital extradural cyst in the thoracic or cervical region is one of spastic paraparesis or quadriparesis of fluctuating but progressive severity. Sensory and autonomic functions are usually involved to a lesser degree than motor function. A congenital extradural cyst in the lumbar area may present with pain, especially pain of a radicular nature.
As the cyst enlarges, it causes enlargement of the spinal canal, which can be identified radiographically. Myelography will reveal an extradural defect. and occasionally the contrast medium will enter the cyst through its pedicle. CT scanning after Myelography enhances the value of the study. MRI is also valuable in establishing the diagnosis.
The overall prognosis of surgically treated cases is good. Usually the cyst can be excised or resected. and the dural defect closed. If the associated cord compression is not too severe or too long­standing, recovery is likely. The key is early recognition and treatment.
Spinal Perineurial Cysts (Tarlov Cysts)
Although such cysts were noted occasionally during the first four decades of the twentieth century, their nature was not elucidated until Tarlov's investigations, first published in 1938. At that time Tarlov was conducting an anatomic study of the filum terminale in about 30 human subjects for another purpose. and in five of the subjects he discovered cysts on the sacral or coccygeal posterior nerve roots in the region where they passed through the dura mater. By studying these and subsequent cases, Tarlov defined the nature of spinal perineurial cysts.
The spinal perineurial cyst arises between the arachnoid that covers a nerve root (perineurium) and the outer surface of its pia (endoneurium), and its walls are formed of these elements. The cyst may extend around the circumference of the nerve or into the substance of the nerve root and dorsal ganglion. It is filled with a clear fluid that probably initially is CSF in communication with the CSF within the spinal subarachnoid space; later this communication may close. Although a spinal perineurial cyst involves a single nerve at first, it may enlarge to the point where it compresses adjacent nerve roots as well.
These cysts typically involve the sacral nerve roots, and they usually were discovered incidentally during myelography, CT scanning, or MR imaging for the evaluation of another condition. However, in at least 60 cases reported between 1948 and 1970, a spinal perineurial cyst has been thought to be the cause of symptoms (especially radicular pain) and signs of nerve root compression.
In the rare instance in which a single Tarlov cyst is causing significant symptoms, surgical excision of the cyst (and its parent root if a water-tight dural closure cannot be achieved otherwise) may provide relief. Since most of these cysts are asymptomatic and are found incidentally, treatment is otherwise not necessary.
Spontaneous Meningeal Diverticula along Spinal Nerve Roots
Meningeal diverticula along spinal nerve roots are not uncommon findings on myelography, CT, or MRI examinations, or during detailed postmortem studies. Like perineurial cysts. these occur in adults of either sex and project laterally into the dorsal root ganglia. They appear to be arachnoid-lined outpouchings that communicate freely with the spinal subarachnoid space. Although they occur along the length of the spine, there is a cervicosacral size gradient. the more cephalad cysts being smaller than those located more caudad (probably a hydrodynamic effect in the upright human being).
On rare occasions a meningeal diverticulum may produce symptoms of nerve root compression. especially in the sacral region. Treatment under this circumstance would be the same as for a symptomatic Tarlov cyst. However. most meningeal diverticula along spinal nerve roots are incidental and do not require treatment.
Occult Intrasacral Meningoceles
The term intrasacral meningocele is actually inaccurate, since a meningocele is ordinarily defined as a herniation of the meninges through a defect in the skull or vertebral column. However, in common usage it denotes a sac composed of fibrous tissue resembling dura mater that is usually lined by arachnoid, lies within an enlarged sacral spinal canal. and is attached to the caudal termination of the dural sac by a narrow or broad pedicle that usually permits the free flow of CSF from the tip of the subarachnoid space into the meningocele.
At least 44 cases of occult intrasacral meningocele were reported between 1932 and 1972. Most of these meningoceles did not become symptomatic until adult life. which suggests that this lesion enlarges with time. probably because of the hydrodynamic effects of the CSF within it.
The intrasacral meningocele displaces the adjacent sacral nerve roots and compresses them against the bony walls of the sacral canal, which is enlarged about the meningocele. This nerve root compression is apparently the cause of the patient's symptoms. The most common complaint is pain in the back with radiating pain and paresthesia in the sciatic distribution of one or both legs. At times hypoesthesia is noted in the same sciatic distribution or in the perineal area. There may also be weakness in one or both legs. Urinary or fecal incontinence or retention are common symptoms and impotence has also been reported. Ordinarily the enlargement of the sacral canal can be seen or suspected on plain roentgenograms and confirmed by myelography, CT or MRI.
Surgical treatment consists of ligating and dividing the pedicle of the meningocele and deflating its sac. Such treatment should relieve the sacral nerve root compression. If the meningocele is associated with tethering of the spinal cord. that condition should also be treated by division of the filum terminale.
Meningeal Diverticula at the Site of Avulsed Spinal Nerve Roots
After traumatic avulsion of one or more cervical nerve roots from the spinal cord, meningeal diverticula are commonly demonstrated by myelography, CT, or MRI at the levels of injury. Such a pseudomeningocele results from a tear of the dura mater and arachnoid with subsequent loculation of the CSF or from a tear in the dura with herniation of the arachnoid through the defect. It may be confined within the spinal canal. but ordinarily it extends out through the intervertebral foramen along the course of the spinal nerve. Usually the traumatic meningeal diverticulum marks the level of the avulsed nerve root, but rarely the pseudomeningocele occurs around or adjacent to an intact nerve root. or an avulsed nerve root exists in the absence of a myelographically demonstrable dural injury.
This same type of traumatic diverticulum can occur in the lumbosacral region in association with avulsion or traction-disruption of one or more of the lower lumbar or upper sacral nerve roots. Traumatic lumbosacral diverticula of this sort are usually seen in association with a fractured pelvis. They are much less common than those in the cervical region.
When one or more meningeal diverticula are demonstrated radiologically after a traction injury to the brachial, lumbar or sacral plexus, this usually indicates not only which nerve root(s) are involved but the fact that the nerve injury is complete and permanent and is not amenable to surgical treatment. The pseudomeningocele(s) themselves ordinarily do not require treatment.
Postoperative or Post-Traumatic Spinal Meningeal Diverticula
A postoperative spinal meningeal diverticulum is ordinarily the result of an intentional or accidental opening of the dura mater land usually of the arachnoid as well) during an operation on the spine, without a watertight closure of the dura at the end of the operation. The CSF leaks out into the planes of operative dissection and becomes encysted by connective tissue as a pseudomeningocele. A post-traumatic spinal meningeal diverticulum may occur in association with any penetrating wound or fracture-dislocation that disrupts the dura mater and arachnoid.
The diverticulum may increase in size because of the direct hydrostatic pressure of the CSF it contains. Most of the reported postoperative diverticula have been in the lower lumbar area, which may simply reflect the distribution of the original condition that was treated surgically (e.g., a ruptured lumbar disc) or may also indicate the importance of CSF pressure in the development of these fluid-filled sacs. As the diverticulum enlarges, it may compress, distort, or entrap the adjacent neural structures. The resulting symptoms and signs will vary according to the specific structure that is compressed. In some cases the CSF enters the diverticulum to such an extent that when the patient assumes an upright position, postural headaches and even syncope may result.
If the presence of a postoperative or post-traumatic spinal pseudomeningocele is suspected, the diagnosis can be verified radiologically. Myelography with postmyelographic CT is the procedure of choice, but MRI may be helpful as well.
The key to the management of postoperative meningeal diverticula is their prevention by avoidance of dural tears and by water­tight closure of dural defects at the initial operation. Closure of such defects with gelatin sponge, oxidized cellulose, muscle stamps, and the like is far less effective than the direct reapproximation of the dural edges with sutures. If prevention fails, the successful treatment of the symptomatic diverticulum is secondary closure of the dural defect, combined with deflation of the diverticulum.
There are two types of cyst that arise from periarticular tissue throughout the body. One has a synovial lining and is called a synovial cyst. The other has no specific lining and is called a ganglion cyst. Such cysts contain viscid or gelatinous material that can range from clear and colorless to turbid or grumous and colored (white to brown).
In 1968, Kao et al. reported two cases of ganglion cyst arising in the extradural periarticular tissues of the lumbar spine. In 1973, Sypert et al. described a patient with a true synovial cyst of a facet joint (which was unusual in that it seemed to be post-traumatic in origin). Since 1968, numerous additional examples of both types of cyst have been reported.
Usually the cyst is unilateral and is located in the posterolateral epidural space, attached to or adjacent to a facet joint. At times it may be adherent to the ligamentum flavum, or rarely, within the interspinous ligament. Most often it occurs in the lumbar area (especially at the L4-L5 level) and comes to medical attention by compressing one or more spinal nerve roots. Spinal ganglion cysts or synovial cysts have been described in bilateral locations and in other areas of the spine, but both situations are unusual.
On myelography a spinal ganglion or synovial cyst produces a posterolateral extradural mass effect. CT scanning or MR imaging shows a rounded posterolateral extradural cystic mass that may contain peripheral calcification. On occasion, such a cyst can be seen to contain gas, perhaps originating from a facet joint. A cyst that communicates with the facet joint (synovial diverticulum) can be imaged by vertebral arthrography, although this technique is not ordinarily required in the management of the usual case.
The standard treatment of a symptomatic spinal ganglion or synovial cyst involves the surgical excision of the cyst. a straight­forward operation that usually provides relief. However. two percutaneous CT-guided approaches to treatment have been reported. The first involves the opacification of a synovial diverticulum by vertebral arthrography. followed by the instillation of a corticosteroid preparation. The second involves the percutaneous biopsy and aspiration of the cyst. It is not yet known whether such approaches will provide better long-term results than surgical excision.
Miscellaneous Spinal Extradural Cysts
Other spinal extradural cysts are rarely encountered in current neurosurgical practice and are mentioned here only for completeness. They include multiple posterior diverticula into the laminae and spinous processes in the lumbo­sacral region in patients with ankylosing spondylitis, aneurysmal bone cysts (occurring more often in the neural arch than in the vertebral body). extradural spinal hydatid cysts t spinal echinococcosis), etc.
Spinal Intradural Cysts
Neurenteric Cysts
During the normal development of the human embryo. a trilaminar germ disc is formed during the third week of development. The outer layer, the ectoderm faces the amniotic cavity. The inner layer, the endoderm faces the yolk sac in the opposite direction. Between these lies the mesoderm. The mesodermal cells that will give rise to the notochord pass forward from Hensen's node under the ectodermal surface. By the eighteenth day, the floor of this tubular notochord and the underlying endoderm disintegrate. The notochordal canal, now known as the neurenteric canal. connects the yolk sac and the amniotic cavity through the blastopore. Thus there is a temporary direct connection between the anlagen of the spinal cord, spine and gastrointestinal tract.
Knowing this, one would predict that malfunctions at this stage of development might result in combined anomalies of the spinal cord, spine and gut. In fact, such combined anomalies have been recognized since the nineteenth century and were classified by Feller and Sternberg in 1929. In 1960, Bentley and Smith unified to some degree the previous hypotheses of the origin of neurenteric malformations, especially those of Feller and Sternberg 1929 and Saunders ( 1943), under the label the split notochord syndrome.
On the basis of different embryologic information. one would expect to occasionally encounter neurenteric cysts within the spinal canal, and such is the case. Between 1926 and 1972, at least 47 intraspinal neurenteric cysts (also known as enterogenous cysts, endodermal cysts, archenteric cysts, gastrocystomas, intestinomas, cystic teratomas, foregut cysts. etc.) were reported. Wilkins and Rossitch subsequently reviewed 72 additional cases of a similar nature. Of the 119 patients. 76 were male and 43 were female. In some instances. abnormalities were noted at birth. The diagnosis was established during the first decade in 41 (34 percent) patients and in the second decade in 27 (23 percent) patients. Only eight of the patients were 50 years old or older.
Of the 119 cysts. 63 were totally or partially in the cervical spinal canal. 53 were totally or partially in the thoracic spinal canal. and 27 were totally or partially in the lumbosacral canal (cysts at the cervicothoracic junction were counted in both cervical and thoracic categories. and cysts at the thoracolumbar junction were counted in both thoracic and lumbosacral categories). The most common cervical or thoracic cyst location (in 57 cases) was anterior or anterolateral to the spinal cord, perhaps with intramedullary involvement as well.
Pathologically, these cysts vary in composition and complexity and form a spectrum that merges with intraspinal teratomas on the one hand and intraspinal dermoids and epidermoids on the other. The simplest examples of intraspinal neurenteric cysts are those lined by a single layer of simple. pseudostratified. or stratified cuboidal or columnar epithelial cells. with or without cilia, lying on a basement membrane and supported by a layer of more or less vascular connective tissue. Varying numbers of the epithelial cells can be demonstrated to contain mucin by appropriate stains. The more complex types have a similar epithelial lining but, in addition, they have one or more of the other elements found along the course of the gastrointestinal tract or tracheobronchial tree.
Intraspinal neurenteric cysts cause the neurological symptoms and signs and the radiologic features one would expect from any slowly enlarging intraspinal mass. Pain in the affected region of the spine is a common and prominent symptom. which may be accompanied by appropriate radicular pain or by meningismus. Unless an early diagnosis is made, the total course of the illness is usually prolonged over many years, often marked by remissions and exacerbations.
Myelography with postmyelographic CT and/or MRI are the best techniques at present for visualizing intraspinal neurenteric cysts and their coexisting vertebral abnormalities. In addition, plain roentgenograms and tomograms may add to the identification and depiction of the vertebral abnormalities. such as anterior or posterior spina bifida, widened vertebral bodies, fused vertebrae, hemivertebrae, and diastematomyelia.
The treatment of intraspinal neurenteric cysts is surgical. They are frequently adherent to the spinal cord or cauda equina to the extent that complete excision is not feasible. but even so. evacuation and partial resection of these lesions is usually followed by the same good results as complete excision. In either case, neurological function usually improves and recurrence after partial resection may take years to become symptomatic.
Epidermoid and Dermoid Cysts
Epidermoid and dermoid cysts are also dealt with elsewhere. They account for 0.2 to 2 percent of the primary spinal tumors seen by neurosurgeons. Among children, however, epidermoid and dermoid cysts comprise 3 to I3 percent of such spinal tumors. and if only the spinal tumors pre­senting within the first year of life are considered. the incidence rises further to 17 percent.
The epidermoid cyst represents one end of a scale of increasing complexity, with the tridermal teratomas at the other end. The wall of an epidermoid cyst is composed of a connective tissue capsule lined by stratified squamous epithelium. The wall of a dermoid cyst is similar, but also exhibits dermal appendages (e.g.. hair follicles, hair, sebaceous glands, and occasional sweat glands). In the walls of both types of cysts, calcium deposits and cholesterol clefts may be found. The connective tissue capsule of those cysts that are attached to, or are located within. the spinal cord are frequently surrounded by a zone of reactive gliosis. The cavity of an epidermoid cyst is filled with white keratinized debris shed from the epithelial lining. The material in a dermoid cyst also contains hair and glandular secretions, and because of the latter the cyst contents may be yellowish with a buttery consistency. More complex cysts lined with stratified squamous epithelium can also be seen.
The contents of both epidermoid and dermoid cysts are quite irritating. If such material enters the spinal subarachnoid space, for example. during a surgical resection of the cyst, it may produce a sterile meningitis followed by a dense chronic arachnoiditis.
Many of the intraspinal epidermoid or dermoid cysts that arise "spontaneously" are seen in association with other congenital anomalies of the spinal cord, the vertebrae and the soft tissues overlying them posteriorly. Posterior spina bifida occulta is common: and posterior dermal sinuses. hypertrichosis. and other dermal abnormalities are also occasionally encountered. Because of these associations, it is thought that solitary intraspinal epidermoid and dermoid cysts probably occur through an error in embryologic development, such as the inadvertent inclusion of cutaneous ectoderm during closure of the neural tube heteroplasia of prospective neural tissue or deficient closure of the posterior portions of an early neurenteric communication.
However, there is also evidence that some intraspinal epidermoid cysts (especially multiple lumbar cysts in the same patient) may have their origin from fragments of skin that are implanted into the spinal canal. such as by lumbar punctures performed without a stylette in the needle. This assertion is supported by several types of evidence. First, the cysts in these cases have rarely been associated with spina bifida occulta. dermal sinus tracts or other congenital anomalies. Second. the cysts have frequently been multiple, have virtually always been extramedullary, and have occurred at the levels of previous lumbar punctures. Third, similar intraspinal epidermoid and dermoid cysts have been encountered in patients who have had epidermis implanted into the spinal canal during the surgical closure of a meningomyelocele. Fourth, it has been shown that fragments of epidermis will lodge within open needles. And finally, epidermoid and dermoid cysts have been produced in experimental animals by the introduction of tiny fragments of skin into the spinal subarachnoid space.
Takeuchi et al. analyzed the reports of 84 intraspinal dermoids and 114 intraspinal epidermoids from the literature.28 Wilkins and Rossitch added 24 intraspinal dermoids and eight intraspinal epidermoids from three other reports. Among the patients whose sex was stated, there were 52 males and 52 females with dermoid cysts, and there were 71 males and 49 females with epidermoid cysts. Of 104 patients with dermoid cysts, 33 were less than 10 years old and 17 were between 10 and 19 years of age: thus, about half presented during the first two decades of life. Similarly, of 120 patients with epidermoid cysts, 30 were less than 10 years old and 24 were between 10 and 19 years of age, again, almost half presented during the first two decades of life.
Using the same sources, it is apparent that most intraspinal dermoid and epidermoid cysts involve the thoracic or lumbar area. Only 15 of 108 dermoid cysts and 6 of 122 epidermoid cysts were located totally or partially within the cervical spine. In contrast, at least 67 of the dermoid cysts and 79 of the epidermoid cysts occurred at or below the thoracolumbar junction. Of 104 intraspinal dermoids, at least 31 were wholly or partially intramedullary in location. Of 114 intraspinal epidermoids, at least 31 were wholly or partially intramedullary.
In regard to associated defects, 25 of 100 patients with dermoid cysts and 17 of 85 patients with epidermoid cysts had posterior spina bifida, and 34 of 100 patients with dermoid cysts and 12 of 85 patients with epidermoid cysts had a posterior dermal sinus tract. When a patient presents with a dermal sinus tract in the lumbosacral or thoracic area, it is likely that the tract extends to an intradural congenital tumour. Among the cases collected by Wright, 11 of 12 sinus tracts in the thoracic region terminated in such a tumour (9 dermoids. 1 epidermoid, and 1 teratoid tumour). as did 31 of 72 lumbosacral sinus tracts.
Epidermoid and dermoid cysts tend to grow slowly within the spinal canal and are usually associated with a long latent period followed by gradually increasing neurological symptoms and signs that are appropriate to the specific location of the cyst. Scoliosis may develop as the cyst enlarges in a child. Frequently, these tumors occur at the level of the conus medullaris and cauda equina. and in addition to the usual symptoms and signs may cause lower spinal rigidity accompanied by spinal hyperlordosis. In these cases, pain is produced if the patient attempts to flatten his back. flex his trunk. or extend his legs. When associated with a dermal sinus, the cysts are usually diagnosed earlier in life, either through investigation of the obvious sinus tract or because of repeated bouts of meningitis.
Plain roentgenograms may reveal associated vertebral anomalies and will also frequently demonstrate focal enlargement of the spinal canal with pedicular erosion and scalloping of the posterior surfaces of the vertebral bodies. In cases in which the cysts are thought to be of iatrogenic origin from lumbar punctures, plain x-ray films are more likely to be normal. Ultrasonography, myelography, CT scanning. and MRI have all proved useful in the diagnostic workup of this lesion.
The treatment of intraspinal epidermoid and dermoid tumors is surgical, although antibiotics and glucocorticosteroids may also be necessary for the management of any concurrent bacterial or chemical meningitis. When a dermal sinus is present, the optimal treatment is complete excision of the entire tract, utilizing prophylactic antibiotics. This is usually best accomplished early in life, before infection has occurred and before any associated intraspinal cyst has reached extensive proportions. The sinus should not be probed or injected because of the danger of introducing bacteria or dermal debris into the spinal canal. If infection is present and there is no significant neurological deficit, operation should be deferred until the infection has been treated adequately. Since dermal sinus tracts in the lumbosacral area may lead upward to a cyst within the conus medullaris, the surgeon should be prepared to follow to that level and to operate intradurally if this is indicated.
Most intraspinal epidermoid and dermoid cysts are located intradurally. A large percentage are intramedullary, but even those which are extramedullary are frequently firmly attached to the spinal cord or cauda equina. especially if the cyst has been previously infected. The cyst should be evacuated, with care taken not to spill its contents into the subarachnoid space. and the accessible portions of the cyst wall should be excised. It is usually wiser to leave any adherent portion rather than risk the neurological damage that may result from attempts to dissect it free. This conservative approach is usually followed by marked and prolonged improvement. even though the cyst may recur years later.
Developmental Arachnoidal Diverticula and Cysts
Developmental intradural spinal arachnoidal diverticula and cysts have been recognized as pathologic entities since at least 1898. They are composed of normal or slightly thickened arachnoid and are filled with a clear colorless fluid that is most likely normal cerebrospinal fluid. There is debate about the origin of these diverticula and cysts, but it is likely that most arise from congenital "faults" in the distribution of the arachnoidal trabeculae, especially in the septum posticum, which divides the posterior spinal subarachnoid space longitudinally in the cervical and thoracic areas. Despite this apparent developmental origin. it is unusual for intraspinal arachnoidal diverticula and cysts to be associated with spinal dysraphism or other congenital anomalies. They rarely occur in families or as part of a congenital syndrome.
The arachnoidal diverticula are common anatomic variations that ordinarily cause no symptoms. They are encountered inciden­tally. The noncommunicating arachnoidal cysts are much less common but also are usually located posterior to the spinal cord. This type of cyst probably originates from the closure of a previously patent diverticulum. (In the present classification scheme, intradural arachnoidal cysts that form as a response to inflammation caused by spinal trauma or surgery, by the presence of blood or a myelographic contrast medium within the subarachnoid space, by bacterial infection, etc. are grouped in a separate category.) As it expands. the developmental spinal intradural arachnoidal cyst can cause progressive spinal cord compression.
The symptoms and signs of a patient with a noncommunicating intradural arachnoidal cyst typically progress over several years. Occasionally. kyphoscoliosis will develop as the cyst enlarges. Sometimes radiographic evidence of enlargement of the spinal canal may be seen. Myelography and postmyelographic CT demonstrate these cysts as nonfilling mass lesions. MRI is now the procedure of choice for the diagnosis of an intradural spinal arachnoid cyst.
Wilkins and Odom collected 67 cases of symptomatic developmental spinal intradural arachnoidal diverticula and cysts from the medical literature through 1971. Of the 66 patients whose sex was specified, 34 were male and 32 were female. The peak age of occurrence was in the fifth decade: only four patients presented in the first decade and only eight in second. Of the 50 cases in which the location of the lesion was specified. 47 were in the posterior or posterolateral aspect of the spinal canal. Only three were in an anterior or anterolateral location, and none was intramedullary. The most common area of the spine affected was the thoracic region, and the second most common area was the cervical region. Other reports of similar diverticula and cysts have appeared since 1971.
Treatment ordinarily consists of a laminectomy with resection of as much of the cyst wall as possible. A portion of the cyst wall may be fused with or consist of the pia mater, making attempts at its complete excision unwise. The patient usually improves and it is unusual for the cyst to recur. However, delayed deterioration of neurological function after initial improvement may occur, perhaps on the basis of spinal cord ischemia or spinal instability. If the cyst extends along many spinal segments is anterior to the cord or recurs after surgical resection, it may be treated to better advantage by shunting its contents into another space such as the peritoneal cavity. Whether the cyst wall is resected or the cyst fluid is shunted, histologic examination of a part of the cyst wall should be performed to establish the diagnosis, because what appears by gross inspection to be an arachnoidal cyst may prove to be a neurenteric or neuroepithelial cyst.
Miscellaneous Spinal Intradural Cysts
Other more unusual types of intradural spinal cyst include inflammatory arachnoidal cyst, ependymal (neuroepithelial) cysts, cystic dilatation of the terminal ventricle, cystic spinal subdural haematoma, spinal cysticercosis, cystic neurilemoma and spinal subdural cysts of undetermined type.

Reuters students nikname Surgeons Hodad hands of Death and destruction


Patient Eilleen Corrigin has blood drawn at an anti-coagulation clinic at the Staten Island University Hospital in Staten Island, New York in this May 7, 2012, file photograph. REUTERS/Allison Joyce/Files
NEW YORK | Thu Sep 27, 2012 9:19am EDT
(Reuters) - When Dr. Marty Makary was a medical student, staffers at the Boston hospital where he was training had a nickname for one of its most popular surgeons: Dr. Hodad.
"Hodad" is an acronym for "hands of death and destruction": Despite his Ivy League credentials and board certification, the surgeon had an unfortunate tendency to botch operations so badly that patients often suffered life-threatening complications.
But he was also one of the surgeons most requested by patients, including celebrities, thanks to his charming bedside manner and their lack of understanding about what caused their post-op problems.
Makary, 42, aims to end the professional code of silence that allows colleagues like Dr. Hodad to thrive. Now a cancer surgeon at Johns Hopkins Hospital in Baltimore, Makary has just published the book "Unaccountable: What Hospitals Won't Tell You and How Transparency Can Revolutionize Health Care."
It outlines the extent to which doctors and hospitals suppress objective data about how patients fare in their hands and argues for clear, publicly accessible statistics to help people make the best choices when it comes to treatment. Hospitals and physicians, he argues, should collect "outcomes data" on everything from how many knee-replacement patients walk without a limp to how many prostatectomy patients become incontinent.
Without that, "patients are walking in blind" every time they choose a hospital, Makary said in an interview. With rare exception they have no way of knowing whether they will receive appropriate care or be one of the 100,000 patients killed or 9 million harmed every year in the United States because of medical mistakes.
"There is terrible guilt about keeping quiet, but there are strong social forces against speaking up when you think something doesn't look right: It can get you fired," said Makary. (HealthGrades, a Denver company that develops and markets quality and safety ratings of healthcare providers, rates Makary a "recognized doctor" based on his training and record of no disciplinary actions or malpractice claims.) "You realize as a young doctor that you've walked into an industry with a very dark side."
CLEAR AS MUD
In no U.S. state can patients find out what a surgeon's rate of complications is, how many mistakes a hospital makes, how many avoidable deaths it has or almost anything else about a provider's record of care.
Most ratings, from magazines to websites, reflect softer metrics. In the closely watched hospital rankings issued by U.S. News & World report, "reputation," or what specialists think of a hospital, counts 32.5 percent toward overall scores. Patient volume, number of nurses, use of advanced technologies and 30-day mortality rates also count.
The federal government collects and makes public some measures, such as hospitals' rates of complications and mortality after certain procedures, on the Hospital Compare website. About half the states require hospitals to make public what percentage of patients develop infections. While that's better than nothing, says Dr. John Santa of Consumers Union, publisher of Consumer Reports, providers have largely succeeded in hiding their records.
"Despite the best efforts, if hospitals don't have to report something they don't," said Santa.
For example, a regular survey by Johns Hopkins asks staffers at 60 hospitals about safety and teamwork. Studies show that hospitals scoring high on the surveys have fewer surgical complications and better patient outcomes. But hospitals participate "under the condition that the results remain top secret," said Makary.
Specialist groups also gather data, including the Society of Thoracic Surgeons, which tracks national heart-surgery outcomes. Only one-third of hospitals have agreed to post their results on the society's website.
Santa believes patients should have far more data on outcomes, such as what fraction of hip-replacement patients develop infections and what fraction of heart-bypass patients survive, not just currently available information on whether providers follow medical guidelines.
The reason? Good practices may not be a reliable proxy for good safety. A hospital's rate of providing antibiotics after surgery, for instance, does not always correlate with patients' infection rate, said Santa.
The Joint Commission, an independent non-profit that certifies and accredits hospitals and other providers, last week released its annual report summarizing how well 3,300 hospitals did on measures of quality and safety.
Patients can see that a particular hospital was a "top performer" in pneumonia care, meeting criteria such as taking blood cultures in the intensive care unit. But unless a hospital was specifically cited for exceptional care, patients have no way of knowing how good or bad relative to others it is.
More outcomes measures - whether that knee replacement patient walks again, or even dies on the operating table - will be made public in coming years, said Nancy Foster, vice president for quality and patient safety policy at the American Hospital Association. Patients typically choose a hospital based on what their doctor or friends recommend, she notes, adding, "I think there is a lot of opportunity to enrich that process with hard data. The measures currently available are not as consumer-friendly as most of us would like."
THE EXCEPTIONS
Makary notes several models of transparency that have shown promise. New York, Oregon and California require hospitals to report death rates from heart bypass surgery, adjusted for how sick patients were and other factors to make the comparisons fair.
Transparency has benefited patients. After New York made its data public in 1989, hospitals scrambled to improve, and death rates from heart surgery fell 41 percent in four years.
Vitals.com, a doctor-reviews site launched in 2008, recently began incorporating outcomes for cancer and orthopedic surgery from a number of large hospitals into its ratings, said chief executive and co-founder Mitch Rothschild.
"Individual facilities recognize that if they don't weed out bad practitioners, they'll get creamed as Medicare starts penalizing hospitals for poor performance, so they collect these metrics and share them with us," he said.
For other outcome data that hospitals chose not to share, Vitals filed a Freedom of Information Act request to access the government's Medicare health program for the elderly.
"After a year and a half, as legal fees mounted, we gave up," Rothschild said. The government maintains the data cannot be made public for reasons of privacy and others.
In the meantime, the pitfalls for patients are many. When Makary looked Dr. Hodad up years later, he was still thriving and had a five-star rating on a popular review website.
Makary regrets keeping quiet during a residency at a university-affiliated community hospital that boasted of its "comprehensive breast cancer center" and "No. 1 ranking."
Both statements were inventions of the hospital's marketing department, which can make all sorts of claims as long as they are vague enough not to fall afoul of truth-in-advertising laws. The assertion that patients "may" or "often" do better at a particular hospital is allowed, for instance, as are subjective terms like "comprehensive."
Based on such claims, a young patient Makary calls "Gretchen" who needed breast-cancer surgery believed she would get superb care.
In reality, the small hospital did only a few dozen such surgeries per year compared with hundreds at major hospitals. It did not have the expertise to do breast-conserving and -reconstruction surgery, nor were its surgeons adept at the latest procedures.
Makary said he was bothered at the time by the hospital's disingenuous claims and worried for Gretchen, though he did not warn her. He did ask if she'd considered other hospitals, but even that placed him "on thin ice with my own job."
The operation was horribly botched, leaving Gretchen deformed. Not knowing any other outcome was possible, Makary said, she considered herself "very blessed" just for being alive.
(Editing by Michele Gershberg and Prudence Crowther)

Wednesday, 29 August 2012

Please sign, So many People Worldwide suffering with Chronic Pain


We are growing, with nealry 1000 signatures! Remember, for every pain sufferer online there are probably 10 or more who do not have access to a computer! Do it for your pain brother or sister! SIGN NOW: Speak up! Shout out! Be heard! Spread the word, "WE WIL BE HEARD AND TREATED WITH DIGNITY!"

Pain sufferers rarely have the chance to make an impact on the policies that affect them on a daily basis. THis is a time that you CAN join an online action to prevent serious restrictions in FDA regulations that could make it extremely difficult for you to get opioid (narcotic) pain medications for more than 90 DAYS....if you have been in pain for a year, you would already be out of luck....for the rest of your life! Hundreds of pain sufferers have joined this cause. Please join and bring some friends and family with you! It is time to SPEAK OUT, STAND UP, and BE HEARD!!!
Please Help to stop PROP's Petition
www.change.org
This petition is for all of us who suffer from chronic pain ! and ou

Monday, 27 August 2012

A PROMPT Response to the PROP Opioid Petition


Monday, August 20, 2012

A “PROMPT” Response to the PROP Opioid Petition

By Guest Author Jeffrey Fudin, BS, PharmD, DAAPM, FCCP
After reading the petition dated July 25, 2012 to the FDA from PROP (Physicians for Responsible Opioid Prescribing) requesting opioid labeling changes [PDF here], Dr. Fudin posted his own thoughts in rebuttal on August 5, 2012 at his PainDr.com blog [PDF here]. Going further, he founded a new organization of healthcare professionals, called PROMPT, to help clarify issues regarding effective and safe opioid prescribing in patients with chronic noncancer pain. Following, is his update on these activities. [Note: all links in this article open in a separate browser window, so you will not lose your place on this page.]
My first reactions to the PROP Petition to the FDA were disbelief; a nagging requisite for swift response, but from a multidisciplinary group of healthcare providers. As a result, “PROMPT” (Professionals for Rational Opioid Monitoring & PharmacoTherapeutics) was born [info here]. Unlike PROP (Physicians for Responsible Opioid Prescribing [website here]), the intent was to include a diversity of healthcare professionals (after all, it takes a whole neighborhood of professionals to adequately address complex chronic pain) and not to assume that prescribers are otherwiseirresponsible if they do not follow the PROP platform.
As of this post, we have partnered with many colleagues from every corner of the United States, in part to repudiate the Petition submitted by PROP. It all started with a blog post [here] that generated some heated debate among well-respected clinicians and other, nonclinical, professionals with extensive therapeutic pain management knowledge.
According to a press release by PROP [here], they admit the major goal of their Petition is not strictly to change opioid labeling; rather, the end game is to preclude drug companies from marketing their opioid products beyond a 100mg daily oral morphine equivalent dose (MED), for no more than 90-days, and with a restriction to only severe pain in noncancer conditions. This was in fact the message portrayed in a rebuttal statement by Andrew Kolodny, MD, president of PROP, in a recent Pain-Topics UPDATE [here].
PROP’s inference, therefore, is that if pharmaceutical companies were limited to marketing their products for severe noncancer pain, and not to exceed 90-days or 100mg MED daily, the use of opioid therapy would somehow be safer. I say, show me the evidence!
Playing devil’s advocate, what does this really mean?
  1. PROP is implying that physician prescribers are so impressionable by marketing that they are otherwise incapable of selecting appropriate therapy based on patient needs rather than a protocol or regulatory mandate. Are physicians really that naïve? I doubt it!
  2. Third party payers could refuse to cover payment for “off-label” opioid prescriptions that do not follow the new labeling requested by the Petition.
    Believe it or not, if one of the signatories on the PROP Petition (or any other prescriber) decided to wander outside of the 100mg MED dosage and/or 90-day limit, any community or hospital pharmacist could legitimately refuse to fill the prescription because it is outside the labeled dosing parameters.

    You say, “no — it’s perfectly legitimate to prescribe off-label.” Think again. For example, oral ketorolac has a 5 day limit because of potential kidney dysfunction, and a competent pharmacist would not fill a prescription for oral ketorolac beyond 5 days.

    PROP is saying opioids are killing people. Specifically, they are bootstrapping their argument to several statements, one of which is “Chronic opioid therapy at high doses is associated with increased risk of overdose death.” A pharmacist would therefore certainly have justification not to fill a prescription falling outside the proposed “new” label changes. Worse yet, if he/she did fill the prescription and the patient overdosed —purposefully, unintentionally, and/or because of opioid combined with sedative-hypnotics (prescribed or unprescribed) — liability to the pharmacist would be escalated.
  3. The liability to prescribing practitioners would similarly increase, legal cases would be less defensible, and legitimate care for patients truly requiring long-term opioid therapy would be more scant than it is now.
  4. A daily dosing limit of 100mg morphine (or its equivalent) is somewhat arbitrary and adhering to that limit would require a range of doses depending on the opioids prescribed, because there is a large disparity in published dose equivalencies among the various opioids [discussed in a prior UPDATE here].
Bob Twillman, PhD, previously dissected and critiqued evidence presented in the PROP Petition very nicely in an UPDATE [here], as did the American Academy of Pain Medicine (AAPM), who graciously allowed us to publish at the PainDr.com blog their rebuttal letter submitted to the FDA [PDF here].
Coincidently, the Joint Commission just released a Sentinel Event Alert entitled “Safe Use of Opioids in Hospitals” [PDF here]. In that, they reference their database reporting on deaths or serious injuries from 2004-2011 in which “47% were wrong dose medication errors, 29% were related to improper monitoring of the patient, and 11% were related to other factors, including excessive dosing, medication interactions, and adverse drug reactions.” The Alert states, “These reports underscore the need for the judicious and safe prescribing and administration of opioids, and the need for appropriate monitoring of patients….”
This illustrates that, even in a controlled hospital environment, patients can die from taking opioids that are improperly dosed, not properly monitored, and/or the result of drug interactions in the acute short-term pain setting — similarly to long-term opioid prescribing in outpatients. This is yet another reason that treatment limited to the arbitrary 90-days chosen by PROP is nonsensical.
It seems that the vital message here is to require intense and ongoing education among opioid prescribers for each and every opioid, whether long-acting or immediate release, and regardless of treatment length. This should include risk stratification, vigilant monitoring parameters, careful titration, and proper dosing.
PROP’s supposition that less marketing will yield less diversion or fewer opioid-related overdoses and deaths is unproven and short-sighted. It may even encourage patients to share medications or seek illegal substances should a new regulation otherwise prevent legitimate patients from receiving opioids prescribed by legitimate clinicians.
Turning back to PROMPT — Professionals for Rational Opioid Monitoring & PharmacoTherapeutics — where are we today?
We presently (as of August 20th) have 31 members from highly regarded clinical practices and varying fields of expertise, and the numbers continue to grow. The most current membership roster is publicly available [here]. On August 17, 2012, we posted our response letter to the FDA [PDF here], which basically supports and piggybacks on AAPM’s well written Petition response (noted above).
The unique quality of our group is that it is multidisciplinary, which the physician membership of AAPM welcomes, as is evident in the closing paragraph of their response letter: “We welcome the opportunity to participate in a dialogue with FDA and other interested parties, including prescribers, pharmacists, behavior health practitioners, other healthcare professionals, the scientific community, government agencies, and patients, in reaching a positive outcome for those Americans who suffer unnecessarily with chronic pain.”
PROMPT is happy to live in the same neighborhood as AAPM and we will continue to build houses for rational caregivers that want to move in! Learn more about PROMPT [here], and there are related blog posts welcoming your opinions [here] and [here]. Let us hear from you.
Jeffrey FudinAbout the Author: Jeffrey Fudin graduated from Albany College of Pharmacy & Health Sciences with his Bachelor of Science (BS) degree in 1981 and completed his Doctor of Pharmacy (PharmD) degree in 1998. He is a Diplomate of the American Academy of Pain Management (DAAPM), a Fellow of the American College of Clinical Pharmacy (FACCP), and a member of several other professional organizations. Since 1982, Dr. Fudin has worked at the Stratton Veterans Administration Medical Center in Albany, NY, where he practices as a Clinical Pharmacy Specialist and Director, PGY-2 Pharmacy Pain Residency Programs. He also is an Adjunct Associate Professor of Pharmacy Practice & Pain Management at the Albany College of Pharmacy & Health Sciences, and has been an Instructor of Pharmacology at SAGE Graduate School of Nursing for several years. He is a Clinical Pharmacy Consultant to Homedical Associates, a service dedicated to serving medically complex patients in their homes. Dr. Fudin is a section editor for the journal Pain Medicine, and was a member of the panel establishing guidelines on the “Use of Chronic Opioids for Chronic Non-Cancer Pain,” a collaborative effort between the American Pain Society and the American Academy of Pain Medicine.

Sunday, 19 August 2012

Stop PROPS proposal Chronic Pain Patients be Heard

Shared with Permission from FB Arach Group,
Now here is a great juxtaposition of issues. If you have chronic pain and you read this you will see exactly why it is so important to stop PROP's proposals.

I received my Monthly issue of AARP magazine today. The front page listed an article by none other than Dr. Oz headlined "Wipe Out Chronic Pain". So my interest was piqued. Among other things Dr. Oz stated, "Here is the game-changing development: Doctors now believe that chronic pain is not merely a symptom of another condition; rather it's a separate disease and should be treated as such." All well and good and I totally agree. 

The next thing I read is a post from an Salem Oregon investigative reporter. She had written an article supportive of PROP and saying some pretty disturbing things about Dr. Perry Fine, one of the first doc
tors to argue in favor of treating non-cancer pain with opioids. Dr. Fine wrote a lengthy rebuttal. The author of the original article was responding to Dr. FIne. She had apparently at least come close to accusing Dr. Fine of being a criminal for his views. And gues what she said in her rebuttal article? Here it is: "I do consider any clinician being encouraged to view pain as a disease and not a symptom as criminal."

So there it is! Someone with an inside link to PROP members basically calling Dr. Oz a CRIMINAL! That alone proves the absurdity of the idea behind PROP. The link below goes to a step by step reply from the person who wrote the article, Marianne Skolek.

I also did some checking on the web page for PROP Dr. Andrew Kolodny is President and first contact person. The Vice President is Michael Von Korff, ScD, and he works for AN INSURANCE COMPANY which runs a doctors group! Note he is not even an MD! My gut told me there was a connection between PROP and the insurance industry. Maybe my gut was right!

http://www.salem-news.com/
articles/august122012/
perry-fine-folo-ms.php

All Chronic Pain Patients Please Sign and have your Voice Heard Worldwide



What happens in the USA and the FDA often travels across the pond to Ireland and Europe we need to have our voices Heard,


We are responsible chronic Pain Patients taking Pain meds to have some sort of quality of life, 


Well, on my soap box for another day. Physicians for Responsible Opioid Prescribing (PROP) has asked the FDA to change wording thta would effectively block drug companies from marketing opioids for ALL chronic pain. The changes would also h
ave the effect of severely limiting any opioid treatment of any chronic pain.

Current science is telling us that chronic pain in many ways is a disease itself, mo matter what the trigger. It can be started by Tarlov cysts arachnoiditis Fibro or disc problems etc.or any other Health  reason for Chronic Pain  but once the chronic pain is there it has a life of its own. Diseases like arachnoiditis do provide chronic triggers to fan the flames. We do not have a way to reverse or eliminate the arachonoidits but we may be able to alter the pain response.

One Salem Oregon Newspaper is a strong supporter of PROP and their petition. Their lead "investigator" has state that it is CRIMINAL to consider chronic pain as a disease and not merely a "symptom". If you had any doubt, that shoud lconvince youthat we need to STOP PROP.

PLEASE get more signatures to our petition. We are at 235:



Wednesday, 15 August 2012

AIMISspine Cyprus


AIMIS Spine - American Institute of Minimally Invasive Spine Surgery
US & International surgeons beyond borders

AIMIS Spine is a World leading Spine Center of excellence bringing together the best Minimally Invasive International and US spine surgeons, in a collective environment for healthcare beyond borders in Cyprus - a highly developed Mediterranean Island and European Union member, where English is widely spoken.

Our institute consists of leading US based International and American professors and surgeons of Minimally Invasive Spine micro surgery, who are collectively the world's best in their field. Each of our surgeons performs hundreds of MIS surgeries each year, bringing an unprecedented medical standard to minimally invasive spine micro surgery - second to none - worldwide!
www.AIMISspine.com
AIMIS Spine has over thirty surgeon members who visit Cyprus for at least 10 days - once or twice a year - in order to perform MIS spine surgeries. Since most of the surgeries performed are day cases, upon completion of the surgery, patients and their companions can also enjoy the benefits of a luxury vacation in Cyprus, one of Europe's top holiday destinations.

Our doctors apply innovative surgical techniques using methods of Minimally Invasive Spine micro surgery, which in most cases, allow the patient to leave the hospital  the same day of surgery. The methods used are so advanced that even several scoliosis cases can be corrected using minimally invasive techniques. The heavy post-surgery effects of traditional methods are minimized and in many cases eliminated.

AIMIS Spine operates within World Class, fully licensed and approved Cypriot private hospitals, of the highest international standards; utilizing their established infrastructure and the support of medical and paramedical staff.

Most importantly, AIMIS Spine has established a unique and differentiated operating approach - we are not just another medical travel company or just another local health care provider. Above all, we offer the highest standards of  healthcare  and any necessary follow-up (back home) through our network of member surgeons.

Prior to your arrival and throughout your stay on the beautiful island of Cyprus you will be cared for by AIMIS’ highly trained concierge staff.  They provide personal attention, to both patients and families, and are on hand to help with any queries or problems should they arise.  Our concierges are professionals with extensive experience in the medical tourism business, are fluent in English and will be there for you every step of the way.